Compare

Nature's Sunshine Products Inc vs BridgeBio Pharma, Inc. vs Zai Lab Ltd vs Arrowhead Pharmaceuticals, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearNature's Sunshine Products Inc
NATR
BridgeBio Pharma, Inc.
BBIO
Zai Lab Ltd
ZLAB
Arrowhead Pharmaceuticals, Inc.
ARWR
Year ended2025-12-312025-12-312025-12-312026-09-30
Revenue$480.14M$502.08M$457.18M$450.82M
Revenue growth (YoY)+5.7%+126.3%+15.0%-45.6%
Gross margin72.4%n/a58.3% (computed)n/a
Operating margin5.2%-104.2%-50.2%-156.9%
Net margin4.3%-146.0%-38.4%-159.1%
Net income$20.45M-$732.94M-$175.54M-$717.13M
EPS (Diluted)$1.06-$3.78-$0.16-$5.11
Operating cash flow$35.32M-$445.91M-$150.79M-$271.95M
Free cash flow$28.84M-$447.01M-$158.89M-$283.94M
Cash & equivalents$93.89M$570.12M$679.57Mn/a
Total assets$261.15M$936.02M$1.17B$1.74B
Total liabilities$99.59M$3.01B$456.88Mn/a
Shareholders' equity$161.55M-$2.09B$715.50M$50.50M
Return on year-end equity12.7%n/a-24.5%n/m
Shares outstanding17.51M194.77M1.11B141.29M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearNature's Sunshine Products IncBridgeBio Pharma, Inc.Zai Lab LtdArrowhead Pharmaceuticals, Inc.
Latest$480.14M
Ended 2025-12-31
$502.08M
Ended 2025-12-31
$457.18M
Ended 2025-12-31
$450.82M
Ended 2026-09-30
1 year earlier$454.36M
Ended 2024-12-31
$221.90M
Ended 2024-12-31
$397.61M
Ended 2024-12-31
$829.45M
Ended 2025-09-30
2 years earlier$445.32M
Ended 2023-12-31
$9.30M
Ended 2023-12-31
$266.72M
Ended 2023-12-31
$3.55M
Ended 2024-09-30
3 years earlier$421.91M
Ended 2022-12-31
$77.65M
Ended 2022-12-31
$212.67M
Ended 2022-12-31
$240.74M
Ended 2023-09-30
4 years earlier$444.08M
Ended 2021-12-31
$69.72M
Ended 2021-12-31
$144.10M
Ended 2021-12-31
$243.23M
Ended 2022-09-30